Home Cart 0 Sign in  
X

[ CAS No. 938443-19-7 ]

{[proInfo.proName]} ,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 938443-19-7
Chemical Structure| 938443-19-7
Chemical Structure| 938443-19-7
Structure of 938443-19-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Bulk Inquiry Add To Cart

Quality Control of [ 938443-19-7 ]

Related Doc. of [ 938443-19-7 ]

Alternatived Products of [ 938443-19-7 ]

Product Details of [ 938443-19-7 ]

CAS No. :938443-19-7 MDL No. :MFCD12755863
Formula : C7H4ClN3O2 Boiling Point : -
Linear Structure Formula :- InChI Key :DJHNDPHQSQMESD-UHFFFAOYSA-N
M.W :197.58 Pubchem ID :40152233
Synonyms :

Calculated chemistry of [ 938443-19-7 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 3.0
Num. H-bond donors : 2.0
Molar Refractivity : 47.99
TPSA : 78.61 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.03 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.94
Log Po/w (XLOGP3) : 0.67
Log Po/w (WLOGP) : 0.26
Log Po/w (MLOGP) : 0.85
Log Po/w (SILICOS-IT) : 2.36
Consensus Log Po/w : 1.02

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.06
Solubility : 1.74 mg/ml ; 0.00878 mol/l
Class : Soluble
Log S (Ali) : -1.9
Solubility : 2.5 mg/ml ; 0.0127 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.39
Solubility : 0.0803 mg/ml ; 0.000406 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.77

Safety of [ 938443-19-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 938443-19-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 938443-19-7 ]
  • Downstream synthetic route of [ 938443-19-7 ]

[ 938443-19-7 ] Synthesis Path-Upstream   1~1

  • 1
  • [ 938443-19-7 ]
  • [ 938443-20-0 ]
YieldReaction ConditionsOperation in experiment
48%
Stage #1: With N-ethyl-N,N-diisopropylamine In toluene at 70℃; for 0.5 h;
Stage #2: With trichlorophosphate In toluene at 20 - 100℃; for 2.5 h;
d) 2,4, 7-Trichloro-pyrido[2,3-d]pyrimidine (Inter.5); To a stirred 0.5 M suspension of the dione (Inter. 4)(1 equiv.) in anhydrous toluene under an inert atmosphere was slowly added diisopropylethylamine (3 equiv.). The reaction mixture was then heated to 700C for 30 minutes and then cooled to room temperature prior to the addition of POCl3 (3 equivalents). The reaction was then heated to 100°C for 2.5 hours before being cooled and concentrated in vacuo to give a crude slurry which was then suspended in EtOAc and filtered through a thin pad of Celite.(TM).. The filtrate was concentrated in vacuo to give a brown, oil which was dissolved in CH2Cl2 and stirred over silica gel for 30 minutes. After this time the silica was removed by filtration, the filtrate concentrated and the crude residue purified by flash chromatography (SiO2) to give the title compound in analytically pure form (48percent yield, 96percent purity), m/z (LC-MS, ESP): 234 [M+H]+ R/T = 4.21 mins
48%
Stage #1: With N-ethyl-N,N-diisopropylamine In toluene at 70℃; for 0.5 h;
Stage #2: With trichlorophosphate In toluene at 100℃; for 2.5 h;
To a stirred 0.5 M suspension of the appropriate dione (1 equiv) in anhydrous toluene under an inert atmosphere was slowly added diisopropylethylamine (3 equiv). The reaction mixture was then heated to 70 0C for 30 minutes and then cooled to room temperature prior to the addition of POCl3 (3 equiv). The reaction was then heated to 100 0C for 2.5 hours before being cooled and concentrated in vacuo to give a crude slurry which was then suspended in EtOAc and filtered through a thin pad of Celite.(TM).. The filtrate was concentrated in vacuo to give a brown, oil which was dissolved in CH2Cl2 and stirred over silica gel for 30 minutes. After this time the silica was removed by filtration, the filtrate concentrated and the crude residue purified by flash chromatography (SiO2) to give the title compound in analytically pure form.2,4,7-Trichloro-ρyrido[2,3-d]pyrimidine- X=N, Y=C, Z=C: (48 percent yield, 96 percent purity) m/z (LC-MS, ESP): 234 [M+H]+ R/T = 4.21 min
0.5 g
Stage #1: With N-ethyl-N,N-diisopropylamine In toluene at 70℃; for 0.5 h;
Stage #2: at 0 - 110℃; for 4 h;
To the reaction bottle 7-chloro-pyrido [2,3-d] pyrimidine -2,4 (1H, 3H)-dione (1.98g, 10mmol), diisopropyl ethylamine (3.87g, 30mmol) and toluene, for 70 °C reaction 30 minutes, cooling dropping POCl 3 (4.59g, 30mmol), 110 °C reaction under 4h to the column product splines, 0.5g, the yield is 21.4percent.
Reference: [1] Patent: WO2007/60404, 2007, A1, . Location in patent: Page/Page column 57; 59
[2] Patent: WO2008/23161, 2008, A1, . Location in patent: Page/Page column 101
[3] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 5, p. 1212 - 1216
[4] Patent: WO2008/23161, 2008, A1, . Location in patent: Page/Page column 102-103
[5] Patent: CN102887895, 2016, B, . Location in patent: Paragraph 0310; 0313; 0314
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 938443-19-7 ]

Amides

Chemical Structure| 21038-66-4

[ 21038-66-4 ]

Pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione

Similarity: 0.87

Chemical Structure| 204933-50-6

[ 204933-50-6 ]

2,3-Dihydropyrido[2,3-d]pyrimidin-4(1H)-one

Similarity: 0.82

Chemical Structure| 56783-85-8

[ 56783-85-8 ]

6-Aminopyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione

Similarity: 0.82

Related Parent Nucleus of
[ 938443-19-7 ]

Other Aromatic Heterocycles

Chemical Structure| 21038-66-4

[ 21038-66-4 ]

Pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione

Similarity: 0.87

Chemical Structure| 204933-50-6

[ 204933-50-6 ]

2,3-Dihydropyrido[2,3-d]pyrimidin-4(1H)-one

Similarity: 0.82

Chemical Structure| 56783-85-8

[ 56783-85-8 ]

6-Aminopyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione

Similarity: 0.82